vm/E+ via Getty Images The last time I wrote about Materialise NV (NASDAQ:MTLS), I suggested that macro headwinds and ongoing investments would probably limit near-term upside, despite the company's favorable valuation. The stock is now up over 20% since then on the back of stronger-than-expected Q2 results. Growth investments and the transition to a cloud-based software business continue to weigh on margins and growth, but Materialise's business appears to be turning the corner. Headwinds should ease over ...

Materialise NV (NASDAQ:MTLS) Q2 2024 Earnings Conference Call July 31, 2024 8:30 AM ET Company Participants Harriet Fried - Investor Relations-Lippert/Heilshorn & Associates Brigitte de Vet - Chief Executive Officer Koen Berges - Chief Financial Officer Conference Call Participants Troy Jensen - Cantor Fitzgerald Jacob Stephan - Lake Street Capital Markets Operator Good day, and thank you for standing by. Welcome to the Q2 2024 Materialise Financial Results Conference Call. At this time, all participants ar ...

Q2 2024 Financial Results Conference call | July 31, 2024 www.materialise.com | NASDAQ: MTLS Safe Harbor Summary This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our intentions, beliefs, assumptions, projections, outlook, analyses or current expectations, plans, objectives, strategies and prospects, both financial and business, i ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors use fundamental analysis and traditional valuation metrics to fi ...

LEUVEN, Belgium, May 22, 2024 (GLOBE NEWSWIRE) -- Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and sophisticated 3D printing solutions, today announced that it will host its Annual General Shareholders' Meeting at 10:00 am CEST on Tuesday, June 4, 2024. The convening notices and other documents pertaining to the Annual General Shareholders' Meeting, including the annual report, are available on Materialise's website at https://investors.materialise.com/governance- docu ...

LEUVEN, Belgium, May 22, 2024 (GLOBE NEWSWIRE) -- Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and sophisticated 3D printing solutions, today announced that it will host its Annual General Shareholders’ Meeting at 10:00 am CEST on Tuesday, June 4, 2024. The convening notices and other documents pertaining to the Annual General Shareholders’ Meeting, including the annual report, are available on Materialise's website at https://investors.materialise.com/governance- docu ...

财务数据和关键指标变化 - 第一季度收入同比下降3.4%至6360万欧元,但医疗业务收入增长8% [15] - 毛利率提升至56.5%,较上年同期的55.9%有所提升 [6] - 调整后EBIT为270万欧元,同比下降47%,调整后EBIT率为4.2% [17] - 调整后EBITDA为810万欧元,同比下降21.4%,调整后EBITDA率为12.7% [17][18] - 净利润为360万欧元,与上年同期持平 [26] - 期末现金储备增至1.29亿欧元,净现金头寸为6920万欧元 [27] 各条业务线数据和关键指标变化 医疗业务 - 医疗业务收入增长8%,医疗软件和医疗设备销售分别增长6%和9% [20] - 调整后EBITDA为790万欧元,EBITDA率保持稳定在30.3% [20] - 进入创伤领域,缩短交货周期,为未来增长奠定基础 [7] - 获得呼吸业务创伤支架项目的IDE批准,以及心血管业务TAVR规划服务的FDA和MDR认证 [7] 软件业务 - 软件业务收入下降8%至1040万欧元 [21] - 软件维护和许可销售收入增长4%,但非经常性收入下降31% [21][22] - 调整后EBITDA下降至110万欧元,EBITDA率为10.4% [21] - 推出面向金属增材制造的e-stage for Metal+软件,帮助用户优化支撑结构生成 [8][9] - 推出QPC过程实验室模块,利用AI和物联网提供可操作的洞见 [10] 制造业务 - 制造业务收入下降11%至2700万欧元 [23] - 调整后EBITDA下降至150万欧元,EBITDA率为5.7% [23] - 认证制造业务在医疗和航空航天领域实现进一步增长 [12] - 原型制造需求疲软拖累了整体业务表现 [23] 各个市场数据和关键指标变化 - 未提及具体市场数据和关键指标变化 公司战略和发展方向及行业竞争 - 公司专注于抓住个性化制造和终端使用产品制造市场的增长机会 [7][8][9] - 在医疗业务方面,进入创伤领域并缩短交货周期,为未来增长奠定基础 [7] - 在软件业务方面,推出面向金属增材制造的e-stage for Metal+软件,以及QPC过程实验室模块,帮助客户提高效率和质量 [8][9][10] - 在制造业务方面,聚焦航空航天和医疗等严格监管的行业,利用自身的认证制造能力实现增长 [12] - 公司正在向云和订阅模式转型,为终端使用产品制造市场的进一步扩张做准备 [11] 管理层对经营环境和未来前景的评论 - 第一季度业绩符合预期,公司基本面保持良好 [6] - 医疗业务保持强劲增长势头,软件和制造业务受到市场环境影响有所下滑 [15] - 公司将继续大幅投资于研发,以开拓新的市场机会,为长期可持续增长奠定基础 [18][60][61] - 对2024年全年的收入和调整后EBIT指引保持不变,仍有信心实现既定目标 [29][30] 问答环节重要的提问和回答 问题1 **Alexander Craeymeersch 提问** 询问制造业务第一季度表现为何如此"例外",是否意味着未来几年该业务的数据也不太可能达到这一水平 [32][33] **Brigitte de Vet 回答** - ACTech业务受产能限制影响,未来有望通过产能扩张实现进一步增长 [36][37] - 去年第一季度的强劲咨询服务收入属于非经常性,难以持续复制 [38][39] - 因此制造业务存在结构性和非结构性因素,未来仍有增长空间 [35][40] 问题2 **Jacob Stephan 提问** 询问制造业务项目量的整体趋势,以及公司在创伤领域的机会 [48][49] **Brigitte de Vet 回答** - 认证制造项目平均规模略大于原型制造项目 [50][51] - 公司已成功进入创伤领域,将是2024年及以后的重要增长动力 [53][54][55][57] 问题3 **Unidentified Analyst 提问** 询问公司持续进行16%的高研发投入的战略考虑和预期回报 [59] **Brigitte de Vet 回答** - 研发投入主要集中在医疗新领域拓展、软件产品升级等战略重点上 [60][61][62] - 公司将继续保持较高的研发投入水平,以保持在新兴市场的领先地位 [63]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE AC ...

Q4 2023 Financial Results Conference Call February 21, 2024 www.materialise.com NASDAQ: MTLS Safe Harbor Summary This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our intentions, beliefs, assumptions, projections, outlook, analyses or current expectations, plans, objectives, strategies and prospects, both financial and business, i ...

财务数据和关键指标变化 - 2023年全年收入增长10.4%至2.561亿欧元 [23][24] - 2023年第四季度收入增长4.1%至6530万欧元 [25] - 2023年全年调整后EBITDA增长65%至3140万欧元 [24] - 2023年第四季度调整后EBITDA增长至850万欧元,占收入13% [25] - 2023年全年实现净利润670万欧元,上年同期亏损220万欧元 [24] - 2023年第四季度净亏损50万欧元,上年同期亏损460万欧元 [25][60] 各条业务线数据和关键指标变化 软件业务 - 2023年全年软件收入增长2%至4440万欧元,调整后EBITDA增长至750万欧元 [51] - 2023年第四季度软件收入下降4%至1130万欧元,但经常性收入增长5% [50] 制造业务 - 2023年全年制造业务收入增长7%至1.1亿欧元,调整后EBITDA为750万欧元 [55] - 2023年第四季度制造业务收入下降2%至2620万欧元,调整后EBITDA下降至60万欧元 [54] 医疗业务 - 2023年全年医疗业务收入增长20%至1.014亿欧元,调整后EBITDA为2650万欧元 [53] - 2023年第四季度医疗业务收入增长15%,调整后EBITDA增长至940万欧元 [52] 各个市场数据和关键指标变化 - 宏观经济和地缘政治环境不确定性持续,对原型制作需求产生负面影响 [14][15] - 但3D打印在灵活、可持续和具有成本效益的生产方面的需求依然强劲 [16][17][18] - 从原型制作向终端产品的转变正在进行,3D打印在更多行业和应用中被采用 [17][18] - 航空航天行业是3D打印应用的一个良好示例,公司与GKN Aerospace等建立了合作关系 [34][35] 公司战略和发展方向及行业竞争 - 公司在软件、硬件和专业知识方面的独特优势,使其在3D打印市场处于领先地位 [20][21][22] - 公司将重点关注医疗业务的持续增长、软件业务在终端产品市场的机会,以及制造业务在选定细分市场的增长 [64][65][66] - 公司将在2024年底前开设新的ACTech铸造制造工厂,以捕捉该领域的机遇 [68] 管理层对经营环境和未来前景的评论 - 宏观经济和地缘政治环境的不确定性将持续至少2024年大部分时间 [64] - 公司将保持对医疗业务、软件业务终端产品市场机会和制造业务选定细分市场的关注 [64][65][66] - 2024年收入预计将增长至2.65-2.75亿欧元,调整后EBIT预计为1100-1400万欧元 [69][73]